Maximum Single Dose of Midodrine
The maximum single dose of midodrine is 20 mg, though this is associated with a high rate (approximately 45%) of severe and persistent supine hypertension and is generally not recommended for routine use. 1
Standard Dosing Parameters
The FDA-approved dosing provides clear guidance on single-dose limits:
- Standard single dose: 10 mg 1
- Maximum tested single dose: 20 mg 1
- Critical safety concern: At 20 mg single doses, severe supine hypertension occurs in approximately 45% of patients 1
Practical Dosing Framework
Starting dose: Begin with 2.5-5 mg per dose, particularly in patients with renal impairment 1
Standard therapeutic dose: 10 mg per dose, administered up to 3 times daily 2, 3, 1
Dose escalation: Can increase to 12.5-15 mg per dose if needed for symptom control 2, 3
Absolute maximum: While 20 mg single doses have been administered, the unacceptably high rate of severe supine hypertension makes this inadvisable for clinical practice 1
Timing and Frequency Considerations
- Doses should be spaced approximately 4 hours apart (can be reduced to 3-hour intervals if required for symptom control) 1
- Never administer after 6 PM or within 4 hours of bedtime to minimize supine hypertension risk 1
- Maximum daily dose studied is 30 mg total (though safety not systematically established at this level) 1
Critical Safety Caveats
Supine hypertension monitoring is mandatory - this is the dose-limiting adverse effect. The risk increases dramatically at single doses above 10 mg 1. Regular blood pressure monitoring in both supine and standing positions is essential, and midodrine should be discontinued if supine blood pressure becomes excessively elevated 1.
For patients with renal impairment, initiate at 2.5 mg per dose as desglymidodrine (active metabolite) is renally excreted 1.